Page last updated: 2024-11-07

prednisone and Cholangiocarcinoma

prednisone has been researched along with Cholangiocarcinoma in 7 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Cholangiocarcinoma: A malignant tumor arising from the epithelium of the BILE DUCTS.

Research Excerpts

ExcerptRelevanceReference
" There was no increase in concurrent immunosuppressives dosage after the conversion."1.29Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation. ( Kaplan, MM; Pedrosa, MC; Rohrer, RM, 1995)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Benarous, X1
Brocheton, C1
Bonnay, C1
Boissel, L1
Crovetto, C1
Lahaye, H1
Guilé, JM1
Theret, P1
Gondry, J1
Foulon, A1
Kim, E1
Yoo, SH1
Chen, Z1
Sousa, JA1
Batista, E1
Demeyer, S1
Fischer, N1
Pellegrino, O1
Ribeiro, AS1
Martins, LL1
Worthy, FR1
Goldberg, SD1
Ranjitkar, S1
Xu, JC1
Asmara, AAGY1
Karna, MB1
Meregawa, PF1
Deslivia, MF1
Carula, BC1
Giostri, GS1
Bebber, F1
Batista, MFDS1
Silva, FBD1
Novak, EM1
Vilela, JCS1
Franco, N1
Campos, G1
Deligne, LM1
Machado, TLA1
Degasperi, FA1
Scatigna, BF1
Falótico, GG1
Romero, V1
Basile, R1
Takata, ET1
Kaleka, CC1
Debieux, P1
Antonioli, E1
Zucconi, E1
Cohen, M1
Ferretti, M1
Bampidis, V2
Azimonti, G2
Bastos, ML2
Christensen, H2
Fašmon Durjava, M2
Kouba, M2
López-Alonso, M2
López Puente, S2
Marcon, F2
Mayo, B2
Pechová, A2
Petkova, M2
Ramos, F2
Sanz, Y2
Villa, RE2
Woutersen, R2
Brantom, P2
Chesson, A2
Westendorf, J2
Manini, P2
Pizzo, F2
Dusemund, B2
Aron, J1
Albert, PS1
Gribble, MO1
Samankul, A1
Senawong, G1
Swatsitang, P1
Sripa, B1
Phaosiri, C1
Kanokmedhakul, S1
Senawong, T1
Sirajudeen, MS1
Alzhrani, M1
Alanazi, A1
Alqahtani, M1
Waly, M1
Unnikrishnan, R1
Muthusamy, H1
Alrubaia, W1
Alanazi, N1
Seyam, MK1
Kashoo, F1
Miraj, M1
Channmgere Govindappa, S1
Alghamdi, KA1
Al-Hussinan, NM1
Wang, Z2
Qu, T1
Qi, H1
Zhao, S1
Shi, H2
Bai, W1
Yu, Y1
Wu, X1
Zhao, P1
Yakubov, S1
Stockerl, WJ1
Tian, X1
Shahin, A1
Mandigma, MJP1
Gschwind, RM1
Barham, JP1
Li, R1
Jiang, D1
Du, P1
Yuan, C1
Cui, X1
Tang, Q1
Zheng, J1
Li, Y1
Lu, K1
Ren, X1
Gao, S1
Zhan, X1
Ramgoolam, KH1
Dolphin, AC1
Shi, Q1
Zhou, YJ1
Fang, JG1
Zhong, X1
Chen, LZ1
Hou, HZ1
Ma, L1
Feng, SZ1
He, JW1
Huang, R1
Wang, YF1
Yang, Y1
Guo, FL1
Li, LJ2
Ruan, XH2
Fu, GM1
Zhao, JZ2
Hou, XK1
Gao, M2
Zheng, XQ2
Zeng, Y1
Huang, DM1
Zhang, JM1
Zhang, H1
Kang, M1
Zhu, J1
Xu, YJ1
Li, SN1
Lai, JM1
Liu, JJ1
Wen, S1
Yan, HH1
Cheng, R1
Zhu, F1
Gao, PF1
Zou, HY1
Huang, CZ1
Wang, J1
AbdElgawad, H1
Zinta, G1
Hornbacher, J1
Papenbrock, J1
Markakis, MN1
Asard, H1
Beemster, GTS1
Fukushi, Y1
Akamine, Y1
Abumiya, M1
Tozawa, N1
Yamashita, T1
Nara, M1
Kameoka, Y1
Takahashi, N2
Miura, M1
Qi, G1
Yu, T1
Li, J1
Guo, Z1
Ma, K1
Jin, Y1
Lucon-Xiccato, T1
Montalbano, G1
Gatto, E1
Frigato, E1
D'Aniello, S1
Bertolucci, C1
Shi, W1
Ge, N1
Yu, S1
Wu, J1
Hu, T1
Wei, J1
Yan, X1
Wang, X1
Lin, K1
Deng, T1
Qu, H1
Ou, H1
Huang, Q1
Gao, B1
Li, X1
Wei, N1
von Haeften, K1
Laarmann, T1
Wabnitz, H1
Möller, T1
Gries, KJ1
Hart, CR1
Kunz, HE1
Ryan, Z1
Zhang, X1
Parvizi, M1
Liu, Y1
Dasari, S1
Lanza, IR1
Perez, HL1
Andonian, C1
Wan, KX1
Potts, D1
Gonzalez, P1
Smith, I1
Kavetska, O1
Ali, AH1
Bi, Y1
Machicado, JD1
Garg, S1
Lennon, RJ1
Zhang, L1
Carey, EJ1
Lindor, KD1
Buness, JG1
Tabibian, JH1
Chari, ST1
Martínez-Sogues, L1
Vila, A1
Roura, X1
Pastor, J1
Novellas, R1
Marco, A1
Cuvertoret-Sanz, M1
Martínez, J1
Solano-Gallego, L1
Sanahuja Martínez, A1
Pascual Moreno, I1
Peña Aldea, A1
Sánchiz Soler, V1
Mora Miguel, F1
Gómez, V1
Michel, JA1
Lidar, M1
Langevitz, P1
Livneh, A1
Weiss, P1
Yosepovich, A1
Pedrosa, MC1
Rohrer, RM1
Kaplan, MM1

Reviews

1 review available for prednisone and Cholangiocarcinoma

ArticleYear
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023

Trials

1 trial available for prednisone and Cholangiocarcinoma

ArticleYear
    Neuropsychiatrie de l'enfance et de l'adolescence, 2023, Volume: 71, Issue:1

    Topics: Acceptance and Commitment Therapy; Adolescent; Adult; Aged; Aldehydes; Alpinia; Animals; Antibodies,

2023

Other Studies

6 other studies available for prednisone and Cholangiocarcinoma

ArticleYear
The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience.
    Journal of gastroenterology, 2020, Volume: 55, Issue:11

    Topics: Aged; Bile Duct Neoplasms; Cholangiocarcinoma; Cholangitis, Sclerosing; Cohort Studies; Female; Foll

2020
Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
    Topics in companion animal medicine, 2019, Volume: 35

    Topics: Animals; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Dog Diseases; Dogs; E

2019
Usefulness of digital cholangioscopy for IgG4-related cholangitis diagnosis and cholangiocarcinoma exclusion.
    Gastroenterologia y hepatologia, 2019, Volume: 42, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Bile Duct Neoplasms; Bile Ducts; Cholangiocarcinoma; Cholangiography

2019
The great mimicker.
    Gastroenterology, 2012, Volume: 143, Issue:6

    Topics: Aged; Autoimmune Diseases; Azathioprine; Biopsy; Cholangiocarcinoma; Diagnosis, Differential; Female

2012
Sclerosing cholangitis associated with systemic sarcoidosis.
    Journal of clinical gastroenterology, 2003, Volume: 36, Issue:1

    Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Cholangiocarcinoma; Cholangitis, Sclerosing; G

2003
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
    Clinical transplantation, 1995, Volume: 9, Issue:4

    Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarc

1995